Sabiedrība ar ierobežotu atbildību farmaceitiskā firma "ANISS"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedPaid out in dividends approximately 70 000 € (3% of equity at the end of the previous year).
Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).
Summary of financial statements2008–2025
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||||||
| Total current assets | 1 204 067 | 894 049 | 857 664 | 934 895 | 1 242 332 | 1 430 624 | 2 806 131 | 3 041 297 | 3 489 072 | 2 676 846 | 2 584 759 | 2 391 437 | 3 085 633 | 1 807 792 | 1 698 975 | 1 045 959 | 2 238 438 | 2 218 921 |
| Total non-current assets | 93 664 | 60 612 | 54 438 | 42 357 | 23 600 | 18 997 | 19 940 | 75 525 | 76 303 | 71 159 | 54 156 | 45 429 | 29 199 | 1 435 837 | 1 976 665 | 2 356 657 | 1 139 459 | 979 824 |
| Total assets | 1 297 731 | 954 661 | 912 102 | 977 252 | 1 265 932 | 1 449 621 | 2 826 071 | 3 116 822 | 3 565 375 | 2 748 005 | 2 638 915 | 2 436 866 | 3 114 832 | 3 243 629 | 3 675 640 | 3 402 616 | 3 377 897 | 3 198 745 |
| Balance sheet — liabilities and equity | ||||||||||||||||||
| Current liabilities | 841 240 | 508 338 | 375 539 | 403 920 | 513 667 | 387 119 | 777 644 | 470 855 | 566 207 | 168 454 | 148 275 | 961 969 | 701 357 | 83 446 | 227 319 | 388 186 | 846 972 | 867 279 |
| Non-current liabilities | 177 638 | 250 627 | 218 347 | 127 087 | 62 224 | 109 | 102 | 423 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 1 018 878 | 758 965 | 593 886 | 531 007 | 575 891 | 387 228 | 777 746 | 471 278 | 566 207 | 168 454 | 148 275 | 961 969 | 701 357 | 83 446 | 227 319 | 388 186 | 846 972 | 867 279 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 91 566 | 24 469 | 121 671 | 128 194 | 243 944 | 373 080 | 534 958 | 598 862 | 466 282 | 480 471 | 509 889 | 718 309 | 938 578 | 746 708 | 288 138 | 285 485 | 127 497 | -129 459 |
| Total equity | 275 966 | 194 469 | 316 140 | 444 334 | 688 278 | 1 061 358 | 2 045 134 | 2 643 996 | 2 999 168 | 2 579 551 | 2 490 640 | 1 474 897 | 2 413 475 | 3 160 183 | 3 448 321 | 3 014 430 | 2 530 925 | 2 331 466 |
| Income statement | ||||||||||||||||||
| Sales revenue | 1 119 495 | 1 512 801 | 1 258 252 | 1 121 348 | 1 101 175 | 1 155 353 | 1 402 289 | 1 844 772 | 1 736 533 | 1 408 258 | 1 327 088 | 1 623 593 | 2 052 684 | 1 855 750 | 1 139 206 | 1 007 303 | 730 551 | 309 145 |
| Operating profit | 111 473 | 6901 | 174 727 | 137 013 | 281 368 | 439 346 | 617 813 | 701 785 | 543 601 | 561 421 | 509 889 | 719 502 | 943 042 | 746 951 | 289 782 | 296 452 | 131 815 | -116 683 |
| Profit before income tax | 111 410 | 33 025 | 143 538 | 150 948 | 281 368 | 439 346 | 617 813 | 701 785 | 543 601 | 561 421 | 509 889 | 719 502 | 943 042 | 746 951 | 289 782 | 296 452 | 131 815 | -116 683 |
| Profit for the reporting year | 91 566 | 24 469 | 121 671 | 128 194 | 243 944 | 373 080 | 534 958 | 598 862 | 466 282 | 480 471 | 509 889 | 718 309 | 938 578 | 746 708 | 288 138 | 285 485 | 127 497 | -129 459 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||||||||
| Employees | 15 | 16 | 15 | 9 | 9 | 8 | 10 | 10 | 10 | 10 | 10 | 12 | 12 | 12 | 11 | 10 | 9 | 9 |
| Calculated dividend | 567 792 | 106 960 | 0 | 0 | 0 | 0 | 0 | 0 | 111 110 | 900 088 | 598 800 | 1 734 052 | 0 | 0 | 0 | 719 376 | 611 002 | 70 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: Sabiedrība ar ierobežotu atbildību farmaceitiskā firma "ANISS"
Overview
Sabiedrība ar ierobežotu atbildību farmaceitiskā firma "ANISS" (reg. no. 40103098468) is a limited liability company. The company was registered in 1993 and has been in the register for 33 years. Registered address: Rīga, Ulbrokas iela 19A.
Financial results
Revenue in 2025 was 309 145 €, down 57,7% on the previous year (730 551 €). From 2008 to 2025, revenue declined by an average of 7,3% per year. This is the company's lowest revenue among the published years (2008–2025). 2025 ended with a loss of 129 459 €. The company was profitable in 17 of the 18 published years. In 2025 the company had 9 employees. Revenue per employee was 34 349 €. At the end of 2025, total assets were 3 198 745 € and equity 2 331 466 € (72,9% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.